Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Applied Dna Scns
(NQ:
APDN
)
0.9284
-0.0816 (-8.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Applied Dna Scns
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
June 06, 2024
Via
Benzinga
Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform
June 05, 2024
Via
ACCESSWIRE
Crude Oil Rises Sharply; Elbit Systems Shares Fall After Q1 Results
May 28, 2024
Via
Benzinga
Exposures
Fossil Fuels
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 28, 2024
Via
Benzinga
Dow Dips Over 100 Points; GameStop Shares Spike higher
May 28, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program
April 25, 2024
Via
ACCESSWIRE
Recap: Applied DNA Sciences Q1 Earnings
February 08, 2024
Via
Benzinga
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
February 08, 2024
Via
ACCESSWIRE
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 28, 2024
Via
Benzinga
US Stocks Mixed; Home Prices Increase In March
May 28, 2024
Via
Benzinga
Applied DNA Announces Pricing of $12 Million Public Offering
May 28, 2024
Via
ACCESSWIRE
Earnings Scheduled For February 8, 2024
February 08, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
Via
Benzinga
Earnings Preview For Applied DNA Sciences
February 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
May 23, 2024
Via
Benzinga
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
May 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 13, 2024
Via
Benzinga
Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML
May 13, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 13, 2024
Via
Benzinga
Why JanOne Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket
May 13, 2024
Via
Benzinga
APDN Stock Earnings: Applied DNA Sciences Beats EPS, Misses Revenue for Q2 2024
May 10, 2024
APDN stock results show that Applied DNA Sciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results
May 10, 2024
Via
ACCESSWIRE
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 10, 2024
Via
ACCESSWIRE
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 24, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 24, 2024
We are starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to read about this morning!
Via
InvestorPlace
Applied DNA Announces 1-For-20 Reverse Stock Split
April 22, 2024
Via
ACCESSWIRE
The Top 5 Analysts Ranked by Marketbeat and Stocks They Cover
April 09, 2024
Analysts rate the stocks, but who rates the analysts? This is a look at five of the highest-rated analysts tracked by Marketbeat.com based on 12-month ROI.
Via
MarketBeat
Topics
Cannabis
Exposures
Cannabis
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 18, 2024
Via
Benzinga
Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start
March 18, 2024
Via
ACCESSWIRE
Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress
March 14, 2024
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.